Found 7 matching trials
Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
PHASE1This study is a single-armed, open-label, multicenter Phase 1/2 study to ev...
Location
Institute of Science Tokyo Hospital
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
N/AThis is a multicenter, open-label, single-arm, long-term follow-up clinical...
Location
Peking University First Hospital
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
PHASE3This is a multicenter, randomized, controlled, open-label, phase III clinic...
Location
Beijing Chao-Yang Hospital, Capital Medical University
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
PHASE1This is an open-label, single-arm Phase I/II clinical study to evaluate the...
Location
China-Japan Friendship Hospital
Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis
PHASE2The goal of this clinical trial is to learn if Equecabtagene Autoleucel(Equ...
Location
Multiple Locations
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
NAThis is a single-center, open-label, exploratory clinical study to evaluate...
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
N/AThis study is a multicenter, observational, single-arm real world study. Th...
Location
Peking University People's Hospital